Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rang in aandelen
#4848
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Aandeelprijs
$2.54
Marktkapitalisatie
$3.04B
Verandering (1 dag)
-0.29%
Verandering (1 jaar)
-10.92%
Land
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Categorie
Healthcare
Omzet van Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Omzet in Jun 2026 TTM: $324.58M
Volgens de laatste financiële rapporten van Jilin Aodong Pharmaceutical Group Co., Ltd. bedraagt de huidige omzet van het bedrijf (TTM) $324.58M. In 2023 behaalde het bedrijf een omzet van $487.26M een stijging ten opzichte van de omzet in het jaar 2022, die $415.81M bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Jilin Aodong Pharmaceutical Group Co., Ltd. van 2000 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $324.58M | -9.25% |
| 2024 | $357.66M | -26.60% |
| 2023 | $487.26M | 17.18% |
| 2022 | $415.81M | 14.72% |
| 2021 | $362.46M | 5.16% |
| 2020 | $344.67M | -22.29% |
| 2019 | $443.52M | -8.22% |
| 2018 | $483.25M | 5.62% |
| 2017 | $457.53M | 16.07% |
| 2016 | $394.17M | 9.63% |
| 2015 | $359.54M | -0.59% |
| 2014 | $361.66M | 12.10% |
| 2013 | $322.61M | 39.17% |
| 2012 | $231.80M | 27.60% |
| 2011 | $181.66M | 7.70% |
| 2010 | $168.67M | 12.29% |
| 2009 | $150.21M | 10.47% |
| 2008 | $135.97M | 17.47% |
| 2007 | $115.75M | 17.31% |
| 2006 | $98.67M | 3.79% |
| 2005 | $95.06M | -4.15% |
| 2004 | $99.18M | 21.83% |
| 2003 | $81.41M | 17.43% |
| 2002 | $69.33M | 28.70% |
| 2001 | $53.87M | 41.79% |
| 2000 | $37.99M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
